Skip to content

Spike Persists for Years; Observed Harms Outweigh Benefits

Day 4 · 5:31:52 · Dr. Peter McCullough

  • ⏳ He reports a patient with intact Pfizer vaccine and spike in blood and skin 3.5 years later, plus MRI myocarditis and PE—contradicting CDC clearance claims.
  • 📚 Supporting papers find mRNA for months; he summarizes a huge safety literature concluding observed harms dwarf theoretical benefits as reinfections milden.
  • 🩸 Commercial spike-antibody RBD titres guide his risk stratification and care, a workup he says most Canadian injured witnesses never received.

Persistence data, risk serology, and harm-benefit judgment years into the rollout.

← NEJM Fatal Myocarditis: One Healthy Death Is One Too Many | Cancer Surge, Oncogenic Mechanisms and Vaccine Code in Tumors →

Transcript

Dr. Peter McCullough · 5:31:52

This is an important paper we just published in the European Society of Medicine. This is my patient. He's taken 3 Pfizer vaccines and we have found the Pfizer vaccine intact and the vaccine spike protein intact in his bloodstream 3.5 years after he took the shot. No wonder people are sick for years. This is not supposed to be in the human bloodstream. We did skin biopsies, two sets of them. We found the vaccine and the spike protein in the skin. He's had MRI-proven myocarditis. He's had blood clots with pulmonary embolism. He had a predisposing factor. He had a blood clot about 8 years before he took the shots. So any reasonable doctor would say, no, you shouldn't take a vaccine that causes blood clots if you're predisposed to blood clots. But under current vaccine policy, everyone irrespective of any condition, should take a vaccine. He worked for a pharmaceutical company. He was told he had to take that to keep his job.

Dr. Peter McCullough · 5:32:52

He's been terribly sick afterwards, and he's a very courageous volunteer to be in research. 3 And a half years after the vaccine— now we've sent this to Health and Human Services, we've sent this to all the U.S. leadership— no response. The CDC says the vaccine is out of the body in a couple days. It's still on their website. It's a bold-faced lie. We are dealing with, at least in some people, a vaccine staying in the body a very long time. This is not the first paper. There's a paper by Brogna and colleagues that have identified the messenger RNA up to 6 months in half of people. There's a paper from Yale finding it about the same duration. We can use reverse qPCR to find the vaccine and we can use direct, uh, radioimmunoassay to find the spike protein. This is alarming. This is probably the most alarming paper I'm showing you. We've analyzed it in two, two papers with over 600 references. And by the way, there are about 600,000 peer-reviewed papers on the COVID-19 pandemic.

Dr. Peter McCullough · 5:33:59

150,000 Deal with the vaccines. 15,000 Deal with vaccine safety. So I'm summarizing what's probably in 15,000 papers. We have nearly 1,000 cited in these two papers. The conclusion is easy to see: the observed harms far outweigh the theoretical benefits. They outweigh the theory. And as the longer we go in the pandemic and people keep getting the infection over and over again and it becomes milder and milder, the observed harms even greater outweigh the theoretical benefits. The observed harms— claiming that a side effect is rare is not an adequate rationale for vaccination. Rarity doesn't matter because vaccines are applied to healthy people. One person is one person too many. Very important paper was published in JAMA demonstrating that the higher antibodies to the spike protein indicate a proxy for the spike protein and symptoms in people after vaccination.

Dr. Peter McCullough · 5:35:08

Now they're antibodies, so they're not directly measuring the spike protein, but the correlation in the peer-reviewed literature is about 0.8 to 0.9. This test is available, it's a commercially available assay, and we rely on it greatly in the United States. The lead test is offered by LabCorp, and it gives a range of binding unit, uh, bind receptor binding domain units per mL. And as a general rule, if one has just had the infection, no vaccine, they're typically below 1,000. Every paper published using this serology, people under 1,000 seem to be free and clear. When people are closer to 5,000, we start to find spike protein in the bloodstream. When we do research assays for this, and people up around 25,000, honestly, they're in trouble. It's a proxy for how much spike protein is in the human body. Let me see a show of hands, how many of you who are vaccine injured have had this test done?

Dr. Peter McCullough · 5:36:09

Just a handful. I can tell you this is a standard of care for any vaccine injured to have a proxy for how, how much the body's been loaded with spike protein. Very low spike antibodies head us in a different direction. Higher levels make us very assured that what's going on is directly related to the spike protein. Risk stratification of who's at risk for a cardiac arrest depends on this antibody level. So I always take a detailed infection history, a vaccine history, measure the antibodies. If they're less than 1,000, no further care is needed. But then if they are higher risk, we go through a series of examinations. This is what I do in my practice. I would wager to say this is higher quality medical care than every single vaccine-injured patient received that's testified in the last 3 days. It's organized, it's peer-reviewed, and it's published. It's all science-backed, and there's actions that I take as a doctor. And under my watch I don't have patients developing new blood clots or cardiac arrests.

Dr. Peter McCullough · 5:37:13

And under my watch, I'm gratified to see people slowly improve. I follow these methods in patients from Canada who are referred to me, and I deliver results. The Canadian doctors are not doing this.